Precancerous Conditions Clinical Trial
Official title:
Phase I/II Study of Chemoprevention With Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva) and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Premalignant Lesions of Head and Neck of Former Smokers
Evaluate effect on cells and patient response to study medications, assess side effects of these medications, and evaluate chemicals in cells that may tell how the drug works, before, and after receiving the study medications.
The purpose of this study is to evaluate the effect on cells and patient response to study
medications, assess the side effects of these medications, and to evaluate chemicals in the
cells that may tell how the drug works, before, and after receiving the study medications.
Approximately 61 patients will participate at Emory Winship Cancer Institute and Emory
Crawford W. Long Hospital in Atlanta, Georgia.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05215860 -
Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates
|
N/A | |
Completed |
NCT04153266 -
Oral Epithelial Dysplasia Informational Needs Questionnaire
|
||
Completed |
NCT01752101 -
Identification of a Plasma Proteomic Signature for Lung Cancer
|
N/A | |
Completed |
NCT01752114 -
Early Diagnosis of Pulmonary Nodules
|
N/A | |
Completed |
NCT00179361 -
Natural History of Oro-pharyngeal Cancer Precursors
|
N/A | |
Completed |
NCT00036283 -
Chemoprevention of Oral Premalignant Lesions
|
Phase 2 | |
Recruiting |
NCT06165614 -
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
|
Phase 1 | |
Not yet recruiting |
NCT01837693 -
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
|
N/A | |
Completed |
NCT00043615 -
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
|
N/A | |
Active, not recruiting |
NCT02158858 -
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
|
Phase 1/Phase 2 | |
Completed |
NCT02323672 -
Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
|
N/A | |
Completed |
NCT00851305 -
Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy
|
N/A | |
Not yet recruiting |
NCT04065737 -
Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization
|
Phase 2 | |
Active, not recruiting |
NCT00655421 -
Oral Cancer Screening in Mumbai, India by Primary Health Care Workers
|
Phase 3 | |
Completed |
NCT00213603 -
Follow-up Modalities of Low Grade Precancerous Bronchial Lesions
|
N/A | |
Completed |
NCT03100045 -
Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
|
Phase 1 |